Literature DB >> 18516094

DOCA-salt treatment enhances responses to endothelin-1 in murine corpus cavernosum.

Fernando S Carneiro1, Fernanda R C Giachini, Victor V Lima, Zidonia N Carneiro, Kênia P Nunes, Adviye Ergul, Romulo Leite, Rita C Tostes, R Clinton Webb.   

Abstract

The penis is kept in the flaccid state mainly via a tonic activity of norepinephrine and endothelins (ETs). ET-1 is important in salt-sensitive forms of hypertension. We hypothesized that cavernosal responses to ET-1 are enhanced in deoxycorticosterone acetate (DOCA)-salt mice and that blockade of ETA receptors prevents abnormal responses of the corpus cavernosum in DOCA-salt hypertension. Male C57BL/6 mice were unilaterally nephrectomized and treated for 5 weeks with both DOCA and water containing 1% NaCl and 0.2% KCl. Control mice were uninephrectomized and received tap water with no added salt. Animals received either the ETA antagonist atrasentan (5 mg x day(-1) x kg(-1) body weight) or vehicle. DOCA-salt mice displayed increased systolic blood pressure (SBP), and treatment with atrasentan decreased SBP in DOCA-salt mice. Contractile responses in cavernosal strips from DOCA-salt mice were enhanced by ET-1, phenylephrine, and electrical field stimulation (EFS) of adrenergic nerves, whereas relaxations were not altered by IRL-1620 (an ETB agonist), acetylcholine, sodium nitroprusside, and EFS of nonadrenergic noncholinergic nerves. PD59089 (an ERK1/2 inhibitor), but not Y-27632 (a Rho-kinase inhibitor), abolished enhanced contractions to ET-1 in cavernosum from DOCA-salt mice. Treatment of DOCA-salt mice with atrasentan did not normalize cavernosal responses. In summary, DOCA-salt treatment in mice enhances cavernosal reactivity to contractile, but not to relaxant, stimuli, via ET-1/ETA receptor-independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18516094      PMCID: PMC2683475          DOI: 10.1139/Y08-031

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  35 in total

1.  Determination of adenosine effects and adenosine receptors in murine corpus cavernosum.

Authors:  Rita C Tostes; Fernanda R C Giachini; Fernando S Carneiro; Romulo Leite; Edward W Inscho; R Clinton Webb
Journal:  J Pharmacol Exp Ther       Date:  2007-05-09       Impact factor: 4.030

Review 2.  Targets for the treatment of erectile dysfunction: is NO/cGMP still the answer?

Authors:  Romulo Leite; Fernanda R C Giachini; Fernando S Carneiro; Kênia P Nunes; Rita C Tostes; Robert C Webb
Journal:  Recent Pat Cardiovasc Drug Discov       Date:  2007-06

3.  ERK1/2 inhibition attenuates cerebral blood flow reduction and abolishes ET(B) and 5-HT(1B) receptor upregulation after subarachnoid hemorrhage in rat.

Authors:  Saema A S Beg; Jacob A Hansen-Schwartz; Petter J Vikman; Cang-Bao Xu; Lars I H Edvinsson
Journal:  J Cereb Blood Flow Metab       Date:  2006-06       Impact factor: 6.200

Review 4.  Cardiovascular disease, metabolic syndrome and erectile dysfunction.

Authors:  Alexander Müller; John P Mulhall
Journal:  Curr Opin Urol       Date:  2006-11       Impact factor: 2.309

5.  Prostaglandins and cyclic nucleotides in the urinary bladder of a rabbit model of partial bladder outlet obstruction.

Authors:  M A Khan; C S Thompson; G D Angelini; R J Morgan; D P Mikhailidis; J Y Jeremy
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1999-11       Impact factor: 4.006

6.  Vascular reactivity of mesenteric arteries and veins to endothelin-1 in a murine model of high blood pressure.

Authors:  Alex A Pérez-Rivera; Gregory D Fink; James J Galligan
Journal:  Vascul Pharmacol       Date:  2005-06       Impact factor: 5.773

7.  Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.

Authors:  H Aoki; M Richmond; S Izumo; J Sadoshima
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

Review 8.  Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions.

Authors:  Carmine Savoia; Ernesto L Schiffrin
Journal:  Clin Sci (Lond)       Date:  2007-06       Impact factor: 6.124

Review 9.  Endothelin receptor antagonists: another potential alternative for cardiovascular diseases.

Authors:  Rita C A Tostes; Marcelo N Muscará
Journal:  Curr Drug Targets Cardiovasc Haematol Disord       Date:  2005-08

10.  Endothelin receptor-mediated vasodilatation: effects of organ culture.

Authors:  David Nilsson; Angelica Wackenfors; Lotta Gustafsson; Martin Ugander; Per Paulsson; Richard Ingemansson; Lars Edvinsson; Malin Malmsjö
Journal:  Eur J Pharmacol       Date:  2007-10-03       Impact factor: 4.432

View more
  7 in total

1.  Erectile function in two-kidney, one-clip hypertensive rats is maintained by a potential increase in nitric oxide production.

Authors:  A Elizabeth Linder; Anne M Dorrance; Thomas M Mills; R Clinton Webb; Romulo Leite
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

Review 2.  Emerging role for TNF-α in erectile dysfunction.

Authors:  Fernando S Carneiro; Robert Clinton Webb; Rita C Tostes
Journal:  J Sex Med       Date:  2010-12       Impact factor: 3.802

3.  New insights into hypertension-associated erectile dysfunction.

Authors:  Kenia Pedrosa Nunes; Hicham Labazi; R Clinton Webb
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-03       Impact factor: 2.894

4.  Metformin treatment improves erectile function in an angiotensin II model of erectile dysfunction.

Authors:  Hicham Labazi; Brandi M Wynne; Rita Tostes; R Clinton Webb
Journal:  J Sex Med       Date:  2013-07-24       Impact factor: 3.802

5.  Endothelin-1 induces contraction of female rat internal pudendal and clitoral arteries through ET(A) receptor and rho-kinase activation.

Authors:  Kyan J Allahdadi; Johanna L Hannan; Rita C Tostes; R Clinton Webb
Journal:  J Sex Med       Date:  2010-04-19       Impact factor: 3.802

6.  Extracellular signal-regulated kinase 1/2 activation, via downregulation of mitogen-activated protein kinase phosphatase 1, mediates sex differences in desoxycorticosterone acetate-salt hypertension vascular reactivity.

Authors:  Fernanda R Giachini; Jennifer C Sullivan; Victor V Lima; Fernando S Carneiro; Zuleica B Fortes; David M Pollock; Maria Helena C Carvalho; R Clinton Webb; Rita C Tostes
Journal:  Hypertension       Date:  2009-11-09       Impact factor: 10.190

7.  TNF-alpha infusion impairs corpora cavernosa reactivity.

Authors:  Fernando S Carneiro; Saiprazad Zemse; Fernanda R C Giachini; Zidonia N Carneiro; Victor V Lima; R Clinton Webb; Rita C Tostes
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.